GS
KYTX icon

Gilead Sciences’s Kyverna Therapeutics KYTX Stock Holding History

Gilead Sciences’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$12.7M Hold
4,126,119
– – 0.99% 7
2025
Q1 		$7.96M Hold
4,126,119
– – 0.67% 6
2024
Q4 		$15.4M Buy
+4,126,119
New +$15.4M 0.99% 6